Literature DB >> 20126289

Synthesis and characterization of a redox- and light-sensitive MRI contrast agent.

Chuqiao Tu1, Elizabeth A Osborne, Angelique Y Louie.   

Abstract

A redox- and light-sensitive, T(1)-weighted magnetic resonance imaging (MRI) contrast agent which tethers a spiropyran(SP)/merocyanine(MC) motif to a Gd-DO3A moiety was synthesized and characterized. When in the dark, the probe is in its MC form which has an r(1) relaxivity of 2.51 mM(-1)s(-1) (60MHz, 37°C). After irradiation with visible light or mixing with NADH, the probe experiences an isomerization and the r(1) relaxivity decreased 18% and 26%, respectively. Additionally, the signal intensity in MRI showed an observable decrease after the compound was mixed with NADH.

Entities:  

Year:  2009        PMID: 20126289      PMCID: PMC2678739          DOI: 10.1016/j.tet.2008.12.020

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  16 in total

1.  In vivo visualization of gene expression using magnetic resonance imaging.

Authors:  A Y Louie; M M Hüber; E T Ahrens; U Rothbächer; R Moats; R E Jacobs; S E Fraser; T J Meade
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

2.  Signal processing at the molecular level.

Authors:  F M Raymo; S Giordani
Journal:  J Am Chem Soc       Date:  2001-05-16       Impact factor: 15.419

Review 3.  Molecular imaging: The latest generation of contrast agents and tissue characterization techniques.

Authors:  Francis G Blankenberg
Journal:  J Cell Biochem       Date:  2003-10-15       Impact factor: 4.429

4.  Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy.

Authors:  Harshad D Vishwasrao; Ahmed A Heikal; Karl A Kasischke; Watt W Webb
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

5.  Photochromically-controlled, reversibly-activated MRI and optical contrast agent.

Authors:  Chuqiao Tu; Angelique Y Louie
Journal:  Chem Commun (Camb)       Date:  2007-01-18       Impact factor: 6.222

6.  Time-resolved optical imaging provides a molecular snapshot of altered metabolic function in living human cancer cell models.

Authors:  Dhruv Sud; Wei Zhong; David G Beer; Mary-Ann Mycek
Journal:  Opt Express       Date:  2006-05-15       Impact factor: 3.894

7.  Alteration of electronic relaxation in MR contrast agents through de-novo ligand design.

Authors:  R B Shukla; K Kumar; R Weber; X Zhang; M Tweedle
Journal:  Acta Radiol Suppl       Date:  1997

8.  Spiropyran-based photochromic polymer nanoparticles with optically switchable luminescence.

Authors:  Ming-Qiang Zhu; Linyong Zhu; Jason J Han; Wuwei Wu; James K Hurst; Alexander D Q Li
Journal:  J Am Chem Soc       Date:  2006-04-05       Impact factor: 15.419

9.  Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.

Authors:  Natarajan Raghunand; Bhumasamudram Jagadish; Theodore P Trouard; Jean-Philippe Galons; Robert J Gillies; Eugene A Mash
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

Review 10.  The power to reduce: pyridine nucleotides--small molecules with a multitude of functions.

Authors:  Nadine Pollak; Christian Dölle; Mathias Ziegler
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

View more
  16 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

2.  Multimodal magnetic-resonance/optical-imaging contrast agent sensitive to NADH.

Authors:  Chuqiao Tu; Ryan Nagao; Angelique Y Louie
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 3.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents.

Authors:  Chuqiao Tu; Angelique Y Louie
Journal:  NMR Biomed       Date:  2012-09-27       Impact factor: 4.044

Review 5.  A review of responsive MRI contrast agents: 2005-2014.

Authors:  Dina V Hingorani; Adam S Bernstein; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2014-10-29       Impact factor: 3.161

Review 6.  Activatable T₁ and T₂ magnetic resonance imaging contrast agents.

Authors:  Chuqiao Tu; Elizabeth A Osborne; Angelique Y Louie
Journal:  Ann Biomed Eng       Date:  2011-02-18       Impact factor: 3.934

Review 7.  Environmentally responsive MRI contrast agents.

Authors:  Gemma-Louise Davies; Iris Kramberger; Jason J Davis
Journal:  Chem Commun (Camb)       Date:  2013-10-28       Impact factor: 6.222

Review 8.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

9.  Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium.

Authors:  Gerald P Guntle; Bhumasamudram Jagadish; Eugene A Mash; Garth Powis; Robert T Dorr; Natarajan Raghunand
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

Review 10.  Redox- and hypoxia-responsive MRI contrast agents.

Authors:  Quyen N Do; James S Ratnakar; Zoltán Kovács; A Dean Sherry
Journal:  ChemMedChem       Date:  2014-05-13       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.